Xianglei Fu
Impact in
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 2
-
- Nanoplatforms for cancer theranostics 5
- Co-authors
- Guimei Lin (11 shared papers)Yanbin Shi (12 shared papers)Xiaogang Zhao (5 shared papers)Yi Huang (4 shared papers)Qifeng Sun (4 shared papers)Shengnan Qiu (11 shared papers)Guangxi Zhai (2 shared papers)Hang Wu (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (2 papers)Journal of Controlled Release (2 papers)Journal of Pharmaceutical Sciences (1 paper)Molecular Pharmaceutics (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Xianglei Fu
17 papers receiving 341 citations
Peers
Comparison fields: 5 of 78
- Pharmaceutical Science 46
- Biomaterials 77
- Pharmacology 31
- Immunology 62
- Biomedical Engineering 121
Countries citing papers authored by Xianglei Fu
This map shows the geographic impact of Xianglei Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglei Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglei Fu more than expected).
Fields of papers citing papers by Xianglei Fu
This network shows the impact of papers produced by Xianglei Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglei Fu. The network helps show where Xianglei Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xianglei Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 103 | |
| 2 | 2019 | 48 | |
| 3 | 2021 | 40 | |
| 4 | 2019 | 33 | |
| 5 | 2022 | 23 | |
| 6 | 2024 | 22 | |
| 7 | 2023 | 19 | |
| 8 | 2024 | 16 | |
| 9 | 2024 | 8 | |
| 10 | 2023 | 8 | |
| 11 | 2025 | 7 | |
| 12 | 2024 | 5 | |
| 13 | 2020 | 5 | |
| 14 | 2025 | 3 | |
| 15 | 2024 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2022 | 1 | |
| 18 | 2025 | 0 |
About Xianglei Fu
Xianglei Fu is a scholar working on Molecular Biology, Biomedical Engineering, Biomaterials, Pharmaceutical Science and Epidemiology, having authored 18 papers that have together received 343 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Immunotherapy and Immune Responses (2 papers), Advanced Drug Delivery Systems (2 papers) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Pharmaceutical Science (46 citations), Biomaterials (77 citations), Pharmacology (31 citations), Immunology (62 citations) and Biomedical Engineering (121 citations). Xianglei Fu has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Guimei Lin, Yanbin Shi, Xiaogang Zhao, Yi Huang, Qifeng Sun, Shengnan Qiu, Guangxi Zhai, Hang Wu, Yujia Zhai and Shan Gao. Their work appears in journals such as Biomedicine & Pharmacotherapy, Journal of Controlled Release, Journal of Pharmaceutical Sciences, Molecular Pharmaceutics and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.